Characterization of the novel HLA-DQB1*03:01:46 variant allele in a French hematopoietic stem cell donor.

Alleles Base Sequence HLA-DQ beta-Chains / genetics Hematopoietic Stem Cells Histocompatibility Testing
HLA-DQB1*03:01:46 NGS human leucocyte antigen novel HLA alleles

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
09 2020
Historique:
received: 23 04 2020
revised: 28 04 2020
accepted: 29 04 2020
pubmed: 6 5 2020
medline: 22 6 2021
entrez: 6 5 2020
Statut: ppublish

Résumé

HLA-DQB1*03:01:46 differs from HLA-DQB1*03:01:01:01 by one nucleotide substitution at codon 142.3 in exon 3.

Identifiants

DOI: 10.1111/tan.13921 PMID: 32367655
pubmed: 32367655
doi: 10.1111/tan.13921
doi:

Substances chimiques

HLA-DQ beta-Chains 0
HLA-DQB1 antigen 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

370-371

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Ma C, Flicek P, SGE M. IPD-IGT/HLA database. Nucl Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Céline Dard (C)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-5843-0842

Ornella Senoussi (O)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.

Sylvie Ferrari-Lacraz (S)

Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, Geneva, Switzerland.

Béatrice Bardy (B)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.

Dominique Masson (D)

Department of Biology and Therapies, Histocompatibility Laboratory, Etablissement Français du sang Auvergne-Rhône-Alpes, Grenoble, France.
ORCID: 0000-0002-6995-4713

Articles similaires

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female

Benchmarking and building DNA binding affinity models using allele-specific and allele-agnostic transcription factor binding data.

Xiaoting Li, Lucas A N Melo, Harmen J Bussemaker
1.00
Alleles Benchmarking Transcription Factors Humans Chromatin Immunoprecipitation Sequencing

FCGR3A V158F gene polymorphism and trastuzumab response in HER2-positive breast cancer patients.

Marwa A Abdel-Wahed, Ghada Sadek Sabbour, Amira I Hamed et al.
1.00
Humans Trastuzumab Receptors, IgG Breast Neoplasms Female

miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1.

Jae Yeon Choi, Hyun Jeong Seok, Dong Hyeon Lee et al.
1.00
Humans Colorectal Neoplasms MicroRNAs Interferon Regulatory Factor-1 Radiation Tolerance

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel...
questionsmedicales.fr › Sciences de l'information › Sources d'information › Services d'information › Documentation › Données de séquences moléculaires › Séquence nucléotidique › Characterization of the novel...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-D › Antigènes HLA-DQ › Chaines bêta des antigènes HLA-DQ › Characterization of the novel...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système hématopoïétique › Cellules de la moelle osseuse › Cellules souches hématopoïétiques › Characterization of the novel...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Characterization of the novel...